enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sotagliflozin - Wikipedia

   en.wikipedia.org/wiki/Sotagliflozin

   Sotagliflozin was approved for medical use in the European Union in April 2019, as Zynquista, for the treatment for type 1 diabetes, [2] and in the United States in May 2023, [3] to reduce the risk of death due to heart failure. [1] [4] The marketing authorization for sotagliflozin was withdrawn in the EU in August 2022. [2]

3. Journal of Cardiac Failure - Wikipedia

   en.wikipedia.org/wiki/Journal_of_Cardiac_Failure

   The Journal of Cardiac Failure is a peer-reviewed medical journal published by Elsevier on behalf of the Heart Failure Society of America. It covers cardiology. The editor-in-chief is Robert Mentz. According to the Journal Citation Reports, the journal has a 2021 impact factor of 5.712. [1]

4. Heart failure - Wikipedia

   en.wikipedia.org/wiki/Heart_failure

   Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome caused by an impairment in the heart's ability to fill with and pump blood.. Although symptoms vary based on which side of the heart is affected, HF typically presents with shortness of breath, excessive fatigue, and bilateral leg swelling. [3]

5. Circulation (journal) - Wikipedia

   en.wikipedia.org/wiki/Circulation_(journal)

   Circulation is a scientific journal published by Lippincott Williams & Wilkins for the American Heart Association.The journal publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research.

6. Management of heart failure - Wikipedia

   en.wikipedia.org/wiki/Management_of_heart_failure

   Sleep apnea is an under-recognized risk factor for heart failure. Uncontrolled sleep apnea may increase the risk of heart failure by up to 140%. [4] Weight reduction – through physical activity and dietary modification, as obesity is a risk factor for heart failure and left ventricular hypertrophy. Effective weight management has been shown ...

7. Finerenone - Wikipedia

   en.wikipedia.org/wiki/Finerenone

   Finerenone, marketed under the brand name Kerendia 10 or 20 mg among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. [8]